Dermatology
Latest News
JAK-inhibitor safety in adolescents with AD: Long-term analyses reported
For abrocitinib, "we're starting to get good numbers of [adolescents] who've had about 2 years of exposure," Dr. Lawrence Eichenfield said.
Latest News
Can online mindfulness and self-compassion training improve quality of life for patients with atopic dermatitis?
"Stress can make the skin worse, but at the same time the skin disease and symptoms cause stress," Dr. Peter A. Lio said.
Latest News
Does Ozempic cause hair loss?
“Some of my patients lose hair when they lose weight, generally as a result of the weight loss itself and not as a side effect of these...
News from the FDA/CDC
FDA approves Yuflyma as ninth adalimumab biosimilar
The manufacturer Celltrion is also seeking an interchangeability designation from the FDA, tentatively expected in the fourth quarter of 2024.
News from the FDA/CDC
FDA approves autoinjector pen for Humira biosimilar, Cyltezo
The drug will be commercially available on July 1, 2023.
Latest News
AD in infancy: Diagnostic advice and treatment tips
Among infants who are growing well and otherwise healthy, the infantile eczema phenotype encompasses AD, seborrheic dermatitis, contact dermatitis...
Latest News
Expunging ‘penicillin allergy’: Your questions answered
Great to hear the enthusiasm for testing for penicillin allergy!
Photo Rounds
Nodule on farmer’s hand
Photo Rounds
Firm nodule following tick bite
Latest News
CDC: Drug-resistant ringworm reported in New York
BY ALICIA AULT
The
Latest News
Facial, hand, and foot dermatitis: Lebrikizumab and dupilumab show efficacy in new studies
"Lebrikizumab was efficacious in clearing and improving facial and hand dermatitis, burdensome and difficult-to-treat areas, in most patients," Dr...